Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 4.235
+0.150 (3.67%)
Aug 20, 2026, 4:09 PM HKT
Lepu Biopharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 684.57 | 853.03 | 401.29 | 426.02 | 669.4 | 155.17 |
Short-Term Investments | - | 1.03 | 11.08 | 8.78 | 8.81 | 59.07 |
Trading Asset Securities | 104.42 | 105.73 | 63.63 | 63.63 | - | - |
Cash & Short-Term Investments | 788.99 | 959.78 | 475.99 | 498.43 | 678.2 | 214.24 |
Cash Growth | 46.75% | 101.64% | -4.50% | -26.51% | 216.57% | -71.86% |
Accounts Receivable | 175.63 | 66.88 | 45.82 | 37.8 | 3.04 | - |
Other Receivables | 123.73 | 27.82 | 35.97 | 17.37 | 22.3 | 0.07 |
Receivables | 299.36 | 94.71 | 81.79 | 55.17 | 25.34 | 0.07 |
Inventory | 74.05 | 51.83 | 22.79 | 29.41 | 24.06 | 24.18 |
Prepaid Expenses | - | 35.97 | 63.89 | 89.36 | 81.62 | 73.34 |
Other Current Assets | - | - | 1.05 | 4.78 | 3.58 | 2.3 |
Total Current Assets | 1,162 | 1,142 | 645.51 | 677.15 | 812.8 | 314.13 |
Property, Plant & Equipment | 989.81 | 1,027 | 1,051 | 1,087 | 1,039 | 978.44 |
Long-Term Investments | 397.38 | 397.35 | 114.07 | 126.69 | 122.39 | 137.97 |
Goodwill | - | 52.64 | 52.64 | 52.64 | 52.64 | 52.64 |
Other Intangible Assets | 584.45 | 448.43 | 382.61 | 381.59 | 398.18 | 422.45 |
Other Long-Term Assets | 31.62 | 31.56 | 34.82 | 59.01 | 104.1 | 176.43 |
Total Assets | 3,166 | 3,100 | 2,281 | 2,384 | 2,529 | 2,082 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 179.74 | 183.83 | 236.14 | 207.61 | 166.13 | 158.82 |
Accrued Expenses | - | 40.34 | 34.48 | 32.88 | 32.51 | 23.96 |
Short-Term Debt | - | - | - | - | 329.63 | 40.41 |
Current Portion of Long-Term Debt | 688.5 | 756.32 | 538.41 | 434.3 | 30.36 | 20 |
Current Portion of Leases | 26.38 | 31.97 | 44.36 | 28.34 | 37.17 | 22.91 |
Current Income Taxes Payable | - | 7.48 | 16.91 | 1 | 1.51 | 1.94 |
Current Unearned Revenue | 8.48 | 0.41 | 0.91 | - | - | 4 |
Other Current Liabilities | 114.55 | 141.71 | 172.31 | 195.43 | 246.49 | 277.02 |
Total Current Liabilities | 1,018 | 1,162 | 1,044 | 899.56 | 843.79 | 549.06 |
Long-Term Debt | 465.61 | 275.55 | 255.94 | 260 | 290.06 | 232.47 |
Long-Term Leases | - | - | 11.46 | 24.18 | 3.09 | 19.48 |
Long-Term Unearned Revenue | 17.48 | 17.66 | 18.02 | 12 | 12 | 12 |
Long-Term Deferred Tax Liabilities | 37.69 | 37.69 | 37.69 | 37.69 | 37.69 | 37.69 |
Other Long-Term Liabilities | 240.09 | 243.92 | 232.27 | 262.17 | 441.79 | 384.29 |
Total Liabilities | 1,779 | 1,737 | 1,599 | 1,496 | 1,628 | 1,235 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,804 | 1,804 | 1,711 | 1,659 | 1,659 | 1,532 |
Additional Paid-In Capital | - | 2,904 | 2,578 | 2,420 | 2,420 | 1,842 |
Retained Earnings | -2,477 | -2,504 | -2,765 | -2,354 | -2,331 | -1,642 |
Comprehensive Income & Other | 2,086 | -817.98 | -820.49 | -828.8 | -847.04 | -894.2 |
Total Common Equity | 1,413 | 1,386 | 702.83 | 896.91 | 900.76 | 836.71 |
Minority Interest | -26.05 | -23.5 | -21.02 | -8.21 | - | 10.37 |
Shareholders' Equity | 1,387 | 1,363 | 681.8 | 888.7 | 900.76 | 847.08 |
Total Liabilities & Equity | 3,166 | 3,100 | 2,281 | 2,384 | 2,529 | 2,082 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,180 | 1,064 | 850.16 | 746.82 | 690.3 | 335.26 |
Net Cash (Debt) | -391.5 | -104.05 | -374.17 | -248.4 | -12.1 | -121.03 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.28 | -0.06 | -0.22 | -0.15 | -0.01 | -0.08 |
Filing Date Shares Outstanding | 1,370 | 1,804 | 1,711 | 1,659 | 1,659 | 1,659 |
Total Common Shares Outstanding | 1,370 | 1,804 | 1,711 | 1,659 | 1,659 | 1,532 |
Working Capital | 144.76 | -19.77 | -398.01 | -222.42 | -30.99 | -234.93 |
Book Value Per Share | 1.03 | 0.77 | 0.41 | 0.54 | 0.54 | 0.55 |
Tangible Book Value | 828.76 | 885.23 | 267.58 | 462.68 | 449.95 | 361.62 |
Tangible Book Value Per Share | 0.61 | 0.49 | 0.16 | 0.28 | 0.27 | 0.24 |
Buildings | - | 713.19 | 660.23 | 45.55 | 45.55 | - |
Machinery | - | 380.34 | 378.64 | 365.38 | 246.16 | 195.06 |
Construction In Progress | - | 20.59 | 22.38 | 628.15 | 661.64 | 633.35 |
Leasehold Improvements | - | 120.67 | 118.91 | 106.03 | 105.71 | 102.42 |